Barcelona-area healthcare institution specializing in mental health research, epidemiological cohort studies, and health intervention implementation across Europe and Latin America.
Parc Sanitari Sant Joan de Déu is a healthcare institution near Barcelona specializing in mental health, epidemiology, and public health research. They run large-scale longitudinal cohort studies on ageing and health trajectories, and conduct implementation research on mental health interventions, medication adherence, and workplace wellbeing. Their work bridges clinical practice with population health, focusing on vulnerable groups and translating research into primary care improvements and health policy recommendations.
Core focus across m-RESIST (treatment-resistant schizophrenia), EMPOWER (workplace mental health), RESPOND (pandemic mental health preparedness), and EquityCancer-LA (vulnerable populations).
Coordinated both ATHLOS (ageing trajectories, largest project at EUR 1.9M) and SYNCHROS (cohort harmonization and integration), and contributed to PERMIT (personalised medicine trials with cohort stratification).
IMA-cRCT focuses on medication adherence interventions in primary care, EquityCancer-LA on cancer early diagnosis implementation, and EMPOWER on workplace health programme delivery.
Both EMPOWER and IMA-cRCT explicitly include cost-effectiveness evaluation and economic modelling as core methodologies.
PERMIT explored machine learning for patient stratification in clinical trials and translational research frameworks.
SAFE-Infusion project addressed IV therapy safety with closed system transfer devices and air removal technology for hazardous drug administration.
In their early H2020 period (2015–2018), the organization focused on building and harmonizing large health databases and longitudinal cohorts — projects like ATHLOS and SYNCHROS centred on epidemiological data integration and prospective patient tracking. From 2019 onward, their work shifted decisively toward applied interventions: mental health system resilience (RESPOND), workplace wellbeing programmes (EMPOWER), medication adherence trials (IMA-cRCT), and equity in cancer diagnosis (EquityCancer-LA). The evolution shows a clear trajectory from data infrastructure and observation toward real-world implementation and health policy impact, with growing attention to machine learning and cost-effectiveness methods.
Moving toward applied health interventions with economic evaluation, particularly in mental health, primary care adherence, and health equity for underserved populations.
Parc Sanitari has a dual role: they coordinate ambitious epidemiological studies (ATHLOS, SYNCHROS) but increasingly participate as third-party experts in larger consortia, contributing domain-specific mental health and implementation research expertise. With 79 unique partners across 24 countries, they operate within broad international networks rather than repeating partnerships. Their frequent third-party status (5 of 9 projects) suggests they are valued for specialized clinical and research contributions that complement larger consortium efforts.
Extensive European and global network spanning 79 unique partners in 24 countries. The EquityCancer-LA project extends their reach into Latin America, giving them unusual geographic breadth for a Spanish healthcare institution.
Their combination of large-scale epidemiological cohort expertise with mental health clinical research is uncommon — most organizations excel at one or the other. They bring proven coordination capacity for multi-country health data harmonization (ATHLOS was a EUR 1.9M coordinated effort), which is difficult to replicate. Their Latin American research connections through EquityCancer-LA also set them apart from typical European health research institutions, offering consortium builders a bridge to global health equity work.
